From lipid numbers to actionable risk decisions.
The CardioLipid Interpreterย is an evidence-based clinical decision-support tool designed to help healthcare professionals analyze lipid panels and translate results into meaningful cardiovascular risk assessments and treatment recommendations. By integrating guideline-informed logic with patient-specific factors, the tool supports precise, personalized lipid management at the point of care.
This tool simplifies the interpretation of complex lipid reports by automatically identifying abnormalities, stratifying atherosclerotic cardiovascular disease (ASCVD) risk, and suggesting appropriate lifestyle and pharmacologic interventions. It helps clinicians move quickly from laboratory values to actionable treatment decisions.
Users input key laboratory and clinical parameters such as:
Total cholesterol
LDL-C, HDL-C, triglycerides
Non-HDL cholesterol (optional auto-calculated)
Patient age and sex
Presence of diabetes
Hypertension status
Smoking status
Known ASCVD (optional)
The system analyzes the data using evidence-based thresholds and generates a structured interpretation.
Lipid abnormality classification
Estimated cardiovascular risk category
Statin eligibility guidance
Treatment intensity suggestions
Lifestyle modification recommendations
Follow-up testing intervals
Secondary target alerts (e.g., triglycerides)
Automated lipid panel interpretation
ASCVD risk stratification support
Guideline-aligned statin recommendations
Non-HDL and ratio calculations
Hypertriglyceridemia alerts
Cardiometabolic risk flags
Quick clinical summary output
Mobile-friendly interface
Cardiologists
General physicians
Endocrinologists
Family medicine clinicians
Preventive cardiology clinics
Clinical pharmacists
Medical residents and students
Speeds lipid interpretation
Improves risk-based treatment decisions
Enhances guideline adherence
Reduces therapeutic inertia
Supports preventive cardiology workflows
Improves patient counseling efficiency
This tool is intended for educational and clinical decision-support purposes only. Final treatment decisions should be individualized based on patient context and current clinical guidelines.